Phytochemicals and Nanotechnology: A Powerful Combination against Breast Cancer

Area of Science:

• Oncology
• Pharmacology
• Nanotechnology

Background:

• Conventional breast cancer therapies face challenges like chemo-resistance, metastasis, and recurrence.
• Phytochemicals, natural compounds with anti-cancer potential, are being explored as alternative agents.
• Limitations of phytochemicals include poor stability, solubility, and short systemic half-life, hindering clinical use.

Purpose of the Study:

• To review recent advances in using phytochemicals for breast cancer prevention and treatment.
• To explore lipid-based nanotechnological approaches for overcoming phytochemical pharmacokinetic limitations.
• To enhance the systemic availability, cytotoxicity, and targeted delivery of phytochemicals against breast cancer.

Main Methods:

• Review of existing literature on phytochemicals and their anti-cancer properties.
• Analysis of nanotechnology applications, specifically lipid-based systems, for drug delivery.
• Evaluation of enhanced pre-clinical anti-cancer activity and clinical translation potential.

Main Results:

• Various phytochemical groups (flavonoids, stilbenes, carotenoids, anthraquinones) demonstrate anti-cancer activity.
• Nanotechnology significantly improves phytochemicals' pharmacokinetic profiles and targeted delivery.
• Combined approaches of phytochemicals and nanotechnology show enhanced pre-clinical efficacy.

Conclusions:

• Phytochemicals represent a promising avenue for novel breast cancer therapeutics.
• Lipid-based nanotechnological strategies are effective in overcoming phytochemical delivery challenges.
• These combined approaches hold potential for improved breast cancer treatment and clinical translation.